Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The comparative value of various employer-sponsored influenza vaccination clinics.

Zimmerman RK, Wiringa AE, Nowalk MP, Lin CJ, Rousculp MD, Mitgang EA, Lee BY.

J Occup Environ Med. 2012 Sep;54(9):1107-17. doi: 10.1097/JOM.0b013e3182677d34.

PMID:
22929797
2.

Improving influenza vaccination rates in the workplace: a randomized trial.

Nowalk MP, Lin CJ, Toback SL, Rousculp MD, Eby C, Raymund M, Zimmerman RK.

Am J Prev Med. 2010 Mar;38(3):237-46. doi: 10.1016/j.amepre.2009.11.011. Epub 2009 Dec 24.

PMID:
20036102
3.

Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza.

Lee BY, Bailey RR, Wiringa AE, Afriyie A, Wateska AR, Smith KJ, Zimmerman RK.

Vaccine. 2010 Aug 23;28(37):5952-9. doi: 10.1016/j.vaccine.2010.07.003. Epub 2010 Jul 8.

4.

Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States.

Clements KM, Meier G, McGarry LJ, Pruttivarasin N, Misurski DA.

Hum Vaccin Immunother. 2014;10(5):1171-80. doi: 10.4161/hv.28221. Epub 2014 Mar 7.

5.

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.

Vaccine. 2008 Jun 2;26(23):2841-8. doi: 10.1016/j.vaccine.2008.03.046. Epub 2008 May 6.

PMID:
18462851
6.

Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach.

Brogan AJ, Talbird SE, Davis AE, Thommes EW, Meier G.

Hum Vaccin Immunother. 2017 Mar 4;13(3):533-542. doi: 10.1080/21645515.2016.1242541. Epub 2016 Oct 26.

7.

Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.

Chit A, Becker DL, DiazGranados CA, Maschio M, Yau E, Drummond M.

Lancet Infect Dis. 2015 Dec;15(12):1459-66. doi: 10.1016/S1473-3099(15)00249-2. Epub 2015 Sep 8.

PMID:
26362172
8.

Economics of influenza vaccine administration timing for children.

Lee BY, Tai JH, Bailey RR, Smith KJ, Nowalk AJ.

Am J Manag Care. 2010 Mar;16(3):e75-e85.

9.

Cost-effectiveness of universal influenza vaccination in a pregnant population.

Roberts S, Hollier LM, Sheffield J, Laibl V, Wendel GD Jr.

Obstet Gynecol. 2006 Jun;107(6):1323-9.

PMID:
16738159
10.

Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial.

Yoo BK, Humiston SG, Szilagyi PG, Schaffer SJ, Long C, Kolasa M.

BMC Health Serv Res. 2015 Nov 16;15:511. doi: 10.1186/s12913-015-1169-5.

11.

The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.

Nagy L, Heikkinen T, Sackeyfio A, Pitman R.

Pharmacoeconomics. 2016 Sep;34(9):939-51. doi: 10.1007/s40273-016-0430-z.

12.
13.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

Vaccine. 2015 Jan 15;33(4):535-41. doi: 10.1016/j.vaccine.2014.11.044. Epub 2014 Dec 6.

14.

Cost effectiveness analysis of elementary school-located vaccination against influenza--results from a randomized controlled trial.

Yoo BK, Humiston SG, Szilagyi PG, Schaffer SJ, Long C, Kolasa M.

Vaccine. 2013 Apr 19;31(17):2156-64. doi: 10.1016/j.vaccine.2013.02.052. Epub 2013 Mar 13.

15.
16.

Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children.

Salleras L, Navas E, Torner N, Prat AA, Garrido P, Soldevila N, Domínguez A.

Hum Vaccin Immunother. 2013 Mar;9(3):707-11. Epub 2013 Jan 7.

17.

Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.

Leung MK, You JH.

Vaccine. 2016 May 11;34(22):2469-76. doi: 10.1016/j.vaccine.2016.04.008. Epub 2016 Apr 11.

PMID:
27079928
18.

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.

Luce BR, Zangwill KM, Palmer CS, Mendelman PM, Yan L, Wolff MC, Cho I, Marcy SM, Iacuzio D, Belshe RB.

Pediatrics. 2001 Aug;108(2):E24.

PMID:
11483834
19.
20.

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.

Thommes EW, Kruse M, Kohli M, Sharma R, Noorduyn SG.

Hum Vaccin Immunother. 2017 Apr 3;13(4):867-876. doi: 10.1080/21645515.2016.1251537. Epub 2016 Nov 18. Review.

Supplemental Content

Support Center